Riskpilot← Back to searchSign inGet full accessCARDIO24 AS
ASActiveOrg 992017368Hunsøya, 4700 VenneslaActivities of fitness centres · NACE 9313Est. 20075 employees
Revenue 2025
NOK 6,6M
+8% vs 2024
EBITDA margin
33.9%
+10% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
NOK 1,4M
+7% vs 2024
| Revenue | NOK 6,6M | +8% |
| EBITDA | NOK 2,2M | +10% |
| Net profit | NOK 1,4M | +7% |
| Total assets | NOK 5,1M | +14% |
| Equity | NOK 3,4M | +14% |
| Employees | 5 | — |
Legal name
CARDIO24 AS
Org number
992017368
Legal form
Aksjeselskap
NACE code
9313 · Activities of fitness centres
Founded
4. desember 2007
Share capital
NOK 300 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Drift av helsestudio samt alt som hermed står i forbindelse.
Address
Hunsøya, 4700 Vennesla
Email
post@cardio24.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 716 | 4 481 | 5 837 | 6 165 | 6 634 |
| Staff expenses | −1 209 | −1 740 | −2 599 | −1 745 | −2 050 |
| EBITDA | 241 | 945 | 1 172 | 2 050 | 2 249 |
| Depreciation & amort. | −202 | −301 | −378 | −369 | −481 |
| EBIT | 39 | 645 | 794 | 1 680 | 1 768 |
| Net financials | −25 | −55 | −13 | 4 | 36 |
| Profit before tax | 14 | 589 | 781 | 1 684 | 1 805 |
| Tax | 3 | 130 | 172 | 371 | 397 |
| Net profit | 11 | 459 | 609 | 1 314 | 1 408 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 344 | 4 037 | 4 082 | 4 439 | 5 069 |
| Equity | 1 398 | 1 857 | 2 467 | 2 980 | 3 388 |
| Long-term debt | 1 457 | 1 110 | 0 | 0 | 0 |
| Short-term debt | 489 | 1 070 | 1 616 | 1 458 | 1 681 |
| Total debt | 1 946 | 2 180 | 1 616 | 1 458 | 1 681 |
EBITDA margin
33.9%
This company
15.8%
Market median
+115% vs market
20212025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20212025
Return on equity
41.5%
This company
18.4%
Market median
+126% vs market
20212025
Net profit margin
21.2%
This company
8.1%
Market median
+162% vs market
20212025
Asset turnover
1.31×
This company
1.12×
Market median
+17% vs market
20212025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2017 | |
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARDIO24 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jorunn Honoré Salvesen | Chief Executive Officer | 0 companies |
| Torfinn Salvesen | Chairman | 0 companies |
| Torfinn Omdal | Board of Directors | 0 companies |